Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels

Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):71-7. doi: 10.1016/j.plefa.2011.10.003. Epub 2011 Nov 1.

Abstract

Although omega-3 (n-3) fatty acids negatively regulate triglyceride biosynthesis, the mechanisms mediating this effect are poorly understood, and emerging evidence suggests that stearoyl-CoA desaturase (Scd1) is required for de novo triglyceride biosynthesis. To investigate this mechanism, we determined the effects of perinatal n-3 deficiency and postnatal repletion on rat liver Scd1 mRNA expression and activity indices (liver 16:1/16:0 and 18:1/18:0 ratios), and determined relationships with postprandial (non-fasting) plasma triglyceride levels. Rats were fed conventional diets with or without the n-3 fatty acid precursor α-linolenic acid (ALA, 18:3n-3) during perinatal development (E0-P100), and a subset of rats fed the ALA- diet were switched to the ALA+ diet post-weaning (P21-P100, repletion). Compared with controls, rats fed the ALA- diet exhibited significantly lower liver long-chain n-3 fatty acid compositions and elevations in monounsaturated fatty acid composition, both of which were normalized in repleted rats. Liver Scd1 mRNA expression and activity indices (16:1/16:0 and 18:1/18:0 ratios) were significantly greater in n-3 deficient rats compared with controls and repleted rats. Among all rats, liver Scd1 mRNA expression was positively correlated with liver 18:1/18:0 and 16:1/16:0 ratios. Plasma triglyceride levels, but not glucose or insulin levels, were significantly greater in n-3 deficient rats compared with controls and repleted rats. Liver Scd1 mRNA expression and activity indices were positively correlated with plasma triglyceride levels. These preclinical findings demonstrate that n-3 fatty acid status is an important determinant of liver Scd1 mRNA expression and activity, and suggest that down-regulation of Scd1 is a mechanism by which n-3 fatty acids repress constitutive triglyceride biosynthesis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Blood Glucose / metabolism
  • Diet
  • Down-Regulation / drug effects
  • Fatty Acids / chemistry
  • Fatty Acids / metabolism
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / metabolism*
  • Fatty Acids, Omega-3 / pharmacology
  • Fatty Acids, Unsaturated / metabolism
  • Female
  • Gene Expression Regulation, Enzymologic / drug effects
  • Insulin / blood
  • Liver / drug effects
  • Liver / enzymology
  • Liver / metabolism*
  • Male
  • Postprandial Period
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Long-Evans
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stearoyl-CoA Desaturase / genetics*
  • Stearoyl-CoA Desaturase / metabolism
  • Triglycerides / biosynthesis
  • Triglycerides / blood*
  • Weaning
  • alpha-Linolenic Acid / administration & dosage
  • alpha-Linolenic Acid / pharmacology

Substances

  • Blood Glucose
  • Fatty Acids
  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated
  • Insulin
  • RNA, Messenger
  • Triglycerides
  • alpha-Linolenic Acid
  • Stearoyl-CoA Desaturase